Skip to content
TrialScanner

NCT04072835

Safety Study of Etripamil Nasal Spray for Patients With Paroxysmal Supraventricular Tachycardia. NODE-303

Phase 3CompletedMISTLeadIQVCollaborator

Registry record

Lead sponsor
Milestone Pharmaceuticals Inc.
Conditions
Paroxysmal Supraventricular Tachycardia
Primary completion
Jan 26, 2023Actual
Completion
Locked
Start
Locked
Enrollment
Locked
Interventions
Locked
Study type
Locked
Results on the registry
Locked
Record last updated
Locked

Open NCT04072835 on ClinicalTrials.gov

Enrollment, interventions, the start and completion dates and the change history are locked on 1 row here. Included with TrialScanner ($9.99 a month) and Signal8 Pro.

Unlock with TrialScanner

Recorded changes

0 changes recorded for this trial. The history, with each previous value, is part of TrialScanner.

Tracking since Nov 12, 2026. Changes before that date are not known to TrialScanner.

    NCT04072835: Safety Study of Etripamil... | TrialScanner